These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11790767)

  • 1. Identification of the critical features of a small peptide inhibitor of JNK activity.
    Barr RK; Kendrick TS; Bogoyevitch MA
    J Biol Chem; 2002 Mar; 277(13):10987-97. PubMed ID: 11790767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK.
    Barr RK; Boehm I; Attwood PV; Watt PM; Bogoyevitch MA
    J Biol Chem; 2004 Aug; 279(35):36327-38. PubMed ID: 15208323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat.
    Ferrer I; Blanco R; Carmona M
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):48-58. PubMed ID: 11597764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel retro-inverso peptide is a preferential JNK substrate-competitive inhibitor.
    Ngoei KR; Catimel B; Milech N; Watt PM; Bogoyevitch MA
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1939-50. PubMed ID: 23792175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.
    Enslen H; Tokumitsu H; Stork PJ; Davis RJ; Soderling TR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10803-8. PubMed ID: 8855261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
    Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
    Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1.
    Ember B; Kamenecka T; LoGrasso P
    Biochemistry; 2008 Mar; 47(10):3076-84. PubMed ID: 18269248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors.
    Fuchs SY; Xie B; Adler V; Fried VA; Davis RJ; Ronai Z
    J Biol Chem; 1997 Dec; 272(51):32163-8. PubMed ID: 9405416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide.
    Ngoei KR; Catimel B; Church N; Lio DS; Dogovski C; Perugini MA; Watt PM; Cheng HC; Ng DC; Bogoyevitch MA
    Biochem J; 2011 Mar; 434(3):399-413. PubMed ID: 21162712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells.
    Mc Gee MM; Campiani G; Ramunno A; Nacci V; Lawler M; Williams DC; Zisterer DM
    J Biol Chem; 2002 May; 277(21):18383-9. PubMed ID: 11856743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides.
    Kelemen BR; Hsiao K; Goueli SA
    J Biol Chem; 2002 Mar; 277(10):8741-8. PubMed ID: 11756441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective interaction of JNK protein kinase isoforms with transcription factors.
    Gupta S; Barrett T; Whitmarsh AJ; Cavanagh J; Sluss HK; Dérijard B; Davis RJ
    EMBO J; 1996 Jun; 15(11):2760-70. PubMed ID: 8654373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
    Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
    Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1.
    Yang SH; Whitmarsh AJ; Davis RJ; Sharrocks AD
    EMBO J; 1998 Mar; 17(6):1740-9. PubMed ID: 9501095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cytoplasmic inhibitor of the JNK signal transduction pathway.
    Dickens M; Rogers JS; Cavanagh J; Raitano A; Xia Z; Halpern JR; Greenberg ME; Sawyers CL; Davis RJ
    Science; 1997 Aug; 277(5326):693-6. PubMed ID: 9235893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse two-hybrid screening identifies residues of JNK required for interaction with the kinase interaction motif of JNK-interacting protein-1.
    Barr RK; Hopkins RM; Watt PM; Bogoyevitch MA
    J Biol Chem; 2004 Oct; 279(41):43178-89. PubMed ID: 15271995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific activation of a c-Jun NH2-terminal kinase isoform and induction of neurite outgrowth in PC-12 cells by staurosporine.
    Yao R; Yoshihara M; Osada H
    J Biol Chem; 1997 Jul; 272(29):18261-6. PubMed ID: 9218464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.
    Ho DT; Bardwell AJ; Abdollahi M; Bardwell L
    J Biol Chem; 2003 Aug; 278(35):32662-72. PubMed ID: 12788955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP and mitogen-activated protein kinases are required for glutamate-dependent cyclic AMP response element binding protein and Elk-1 phosphorylation in the dorsal striatum in vivo.
    Choe ES; McGinty JF
    J Neurochem; 2001 Jan; 76(2):401-12. PubMed ID: 11208903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.